Importance of Swift Event Adjudication of Endpoints for Adequate Reporting to Data and Safety Monitoring Boards in Clinical Trials-lessons from CULPRIT-SHOCK
Overview
Overview
Journal
Trials
Publisher
Biomed Central
Specialties
General Medicine
Pharmacology
Pharmacology
Date
2021 Mar 9
PMID
33685472
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R
. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med. 2017; 377(25):2419-2432.
DOI: 10.1056/NEJMoa1710261.
View
2.
Carcillo J, Dean J, Holubkov R, Berger J, Meert K, Anand K
. The randomized comparative pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. Pediatr Crit Care Med. 2011; 13(2):165-73.
PMC: 3302948.
DOI: 10.1097/PCC.0b013e31823896ae.
View
3.
Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C
. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med. 2018; 378(21):1965-1975.
DOI: 10.1056/NEJMoa1800385.
View
4.
Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G
. One-Year Outcomes after PCI Strategies in Cardiogenic Shock. N Engl J Med. 2018; 379(18):1699-1710.
DOI: 10.1056/NEJMoa1808788.
View
5.
De Bruyne B, Pijls N, Kalesan B, Barbato E, Tonino P, Piroth Z
. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012; 367(11):991-1001.
DOI: 10.1056/NEJMoa1205361.
View